[S02DA03, antipyrine, The risk or severity of hypertension can be increased when Linezolid is combined with Antipyrine.]
[B01AD01, streptokinase, Linezolid may increase the orthostatic hypotensive activities of Streptokinase.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Linezolid.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Linezolid.]
[L04AA27, fingolimod, Linezolid may increase the immunosuppressive activities of Fingolimod.]
[J01EC02, sulfadiazine, Linezolid may increase the hypoglycemic activities of Sulfadiazine.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Linezolid.]
[M04AB02, sulfinpyrazone, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, Linezolid may increase the hypoglycemic activities of Sulfisoxazole.]
[M01AB02, sulindac, The risk or severity of hypertension can be increased when Linezolid is combined with Sulindac.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Linezolid is combined with Sulpiride.]
[N03AX03, sulthiame, The therapeutic efficacy of Sulthiame can be decreased when used in combination with Linezolid.]
[A10BB04, glibornuride, Linezolid may increase the hypoglycemic activities of Glibornuride.]
[A10BC01, glymidine, Linezolid may increase the hypoglycemic activities of Glymidine.]
[M01AX04, apazone, The risk or severity of hypertension can be increased when Linezolid is combined with Azapropazone.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Linezolid is combined with Mercaptopurine.]
[L01CB02, teniposide, The risk or severity of adverse effects can be increased when Teniposide is combined with Linezolid.]
[R03CC03, terbutaline, The risk or severity of hypertension can be increased when Linezolid is combined with Terbutaline.]
[B01AE07, dabigatran etexilate, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Dabigatran etexilate.]
[N07XX06, tetrabenazine, The risk or severity of adverse effects can be increased when Linezolid is combined with Tetrabenazine.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Tetracaine.]
[S03AA02, tetracycline, The excretion of Tetracycline can be decreased when combined with Linezolid.]
[N05AE05, lurasidone, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Lurasidone.]
[N04BC07, apomorphine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Apomorphine.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Linezolid is combined with Thalidomide.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Linezolid is combined with Eribulin.]
[R06AD03, thiethylperazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Thiethylperazine.]
[L01AC01, thiotepa, The risk or severity of adverse effects can be increased when Linezolid is combined with Thiotepa.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Linezolid.]
[N05CA19, thiopental, Linezolid may increase the orthostatic hypotensive activities of Thiopental.]
[N05AB08, thioproperazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Thioproperazine.]
[N05AC02, thioridazine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Linezolid is combined with Thiothixene.]
[G04BE06, moxisylyte, The risk or severity of hypertension can be increased when Linezolid is combined with Moxisylyte.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Linezolid is combined with Tiapride.]
[B01AC05, ticlopidine, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Ticlopidine.]
[N02AX01, tilidine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Tilidine.]
[S01ED01, timolol, Linezolid may increase the hypotensive activities of Timolol.]
[A10BB05, tolazamide, Linezolid may increase the hypoglycemic activities of Tolazamide.]
[M02AX02, tolazoline, Linezolid may increase the hypotensive activities of Tolazoline.]
[V04CA01, tolbutamide, Linezolid may increase the hypoglycemic activities of Tolbutamide.]
[M02AA21, tolmetin, The risk or severity of hypertension can be increased when Tolmetin is combined with Linezolid.]
[N02AX02, tramadol, The risk or severity of serotonin syndrome and seizure can be increased when Linezolid is combined with Tramadol.]
[N06AF04, tranylcypromine, The risk or severity of serotonin syndrome can be increased when Tranylcypromine is combined with Linezolid.]
[C01DX11, trapidil, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Trapidil.]
[N06AX05, trazodone, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Trazodone.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Linezolid is combined with Tretinoin.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Linezolid is combined with Triamcinolone.]
[C03DB02, triamterene, Linezolid may increase the orthostatic hypotensive activities of Triamterene.]
[C03AA06, trichlormethiazide, Linezolid may increase the hypotensive activities of Trichlormethiazide.]
[N05AB06, trifluoperazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Trifluoperazine.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Linezolid.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Linezolid is combined with Trifluperidol.]
[N05AA05, triflupromazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Triflupromazine.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Linezolid is combined with Fluclorolone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Linezolid is combined with Mometasone.]
[R06AD01, trimeprazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Alimemazine.]
[N03AC02, trimethadione, The therapeutic efficacy of Trimethadione can be decreased when used in combination with Linezolid.]
[C02BA01, trimethaphan, Linezolid may increase the hypotensive activities of Trimethaphan.]
[N06AA06, trimipramine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Trimipramine.]
[N06AX24, vilazodone, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Vilazodone.]
[N06AX02, tryptophan, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Tryptophan.]
[C09CA09, azilsartan medoxomil, Linezolid may increase the hypotensive activities of Azilsartan medoxomil.]
[R03DX07, roflumilast, Roflumilast may increase the immunosuppressive activities of Linezolid.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Belimumab.]
[A10BH05, linagliptin, Linezolid may increase the hypoglycemic activities of Linagliptin.]
[B01AD04, urokinase, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Urokinase.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Linezolid is combined with Belatacept.]
[N03AX21, ezogabine, The therapeutic efficacy of Ezogabine can be decreased when used in combination with Linezolid.]
[B01AF01, rivaroxaban, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Rivaroxaban.]
[R03AC18, indacaterol, The risk or severity of hypertension can be increased when Linezolid is combined with Indacaterol.]
[B01AC24, ticagrelor, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Ticagrelor.]
[C08DA01, verapamil, Linezolid may increase the orthostatic hypotensive activities of Verapamil.]
[N06AX09, viloxazine, The risk or severity of hypertension can be increased when Viloxazine is combined with Linezolid.]
[L01CA01, vinblastine, The risk or severity of adverse effects can be increased when Vinblastine is combined with Linezolid.]
[C04AX07, vincamine, Linezolid may increase the hypotensive activities of Vincamine.]
[L01CA02, vincristine, The risk or severity of adverse effects can be increased when Vincristine is combined with Linezolid.]
[L01CA03, vindesine, The risk or severity of adverse effects can be increased when Vindesine is combined with Linezolid.]
[B03BA01, vitamin B12, The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Linezolid.]
[B01AA03, warfarin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Warfarin.]
[N01AX15, xenon, The risk or severity of adverse effects can be increased when Xenon is combined with Linezolid.]
[C03BA10, xipamide, Linezolid may increase the hypotensive activities of Xipamide.]
[J05AF01, zidovudine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Linezolid.]
[N05AF05, zuclopenthixol, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Zuclopenthixol.]
[N03AX14, levetiracetam, The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Linezolid.]
[L01FX05, brentuximab vedotin, The risk or severity of adverse effects can be increased when Linezolid is combined with Brentuximab vedotin.]
[B01AE01, desirudin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Lepirudin.]
[N05AE04, ziprasidone, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Ziprasidone.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Linezolid.]
[N02BA01, aspirin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The risk or severity of adverse effects can be increased when Linezolid is combined with Ruxolitinib.]
[J01DH04, doripenem, The excretion of Doripenem can be decreased when combined with Linezolid.]
[C07AB03, atenolol, Linezolid may increase the hypotensive activities of Atenolol.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Linezolid.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Linezolid.]
[S01FA01, atropine, The risk or severity of hypertension can be increased when Linezolid is combined with Atropine.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Linezolid is combined with Prednylidene.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Linezolid is combined with Azacitidine.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Linezolid is combined with Azathioprine.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Linezolid.]
[M03BX01, baclofen, The risk or severity of hypotension can be increased when Baclofen is combined with Linezolid.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Linezolid.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Linezolid.]
[A08AA11, lorcaserin, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Lorcaserin.]
[G04BD12, mirabegron, The risk or severity of hypertension can be increased when Linezolid is combined with Mirabegron.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Linezolid is combined with Carfilzomib.]
[L01EA04, bosutinib, The risk or severity of adverse effects can be increased when Linezolid is combined with Bosutinib.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Linezolid is combined with Teriflunomide.]
[B01AX01, defibrotide, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Defibrotide.]
[C01CA18, octopamine, The risk or severity of hypertension can be increased when Linezolid is combined with Octopamine.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Linezolid is combined with Abetimus.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Linezolid is combined with Aldosterone.]
[N05CA04, barbital, The therapeutic efficacy of Barbital can be decreased when used in combination with Linezolid.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Linezolid is combined with Bendamustine.]
[S01GA07, brimonidine, The metabolism of Brimonidine can be decreased when combined with Linezolid.]
[N04BD02, rasagiline, The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Linezolid.]
[C08CA13, lercanidipine, Linezolid may increase the hypotensive activities of Lercanidipine.]
[A03FA09, mosapride, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Mosapride.]
[N03AX22, perampanel, The therapeutic efficacy of Perampanel can be decreased when used in combination with Linezolid.]
[L04AA29, tofacitinib, Linezolid may increase the immunosuppressive activities of Tofacitinib.]
[N02CC03, zolmitriptan, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Zolmitriptan.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Diethyl ether is combined with Linezolid.]
[L01EA05, ponatinib, The risk or severity of adverse effects can be increased when Linezolid is combined with Ponatinib.]
[B01AF02, apixaban, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Apixaban.]
[A10BH04, alogliptin, Linezolid may increase the hypoglycemic activities of Alogliptin.]
[C03AA01, bendroflumethiazide, Linezolid may increase the hypotensive activities of Bendroflumethiazide.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Linezolid is combined with Pomalidomide.]
[N02BA10, benorilate, The risk or severity of hypertension can be increased when Linezolid is combined with Benorilate.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Linezolid is combined with Benperidol.]
[A10BK02, canagliflozin, Linezolid may increase the orthostatic hypotensive activities of Canagliflozin.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Linezolid is combined with Dimethyl fumarate.]
[A06AX06, tegaserod, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Tegaserod.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Linezolid is combined with Insulin detemir.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Benzocaine.]
[A10BX05, pramlintide, Linezolid may increase the hypoglycemic activities of Pramlintide.]
[M01AH01, celecoxib, The risk or severity of hypertension can be increased when Celecoxib is combined with Linezolid.]
[N02CC02, naratriptan, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Naratriptan.]
[L04AA18, everolimus, The risk or severity of adverse effects can be increased when Linezolid is combined with Everolimus.]
[R02AX03, benzydamine, The risk or severity of hypertension can be increased when Linezolid is combined with Benzydamine.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Benzyl alcohol.]
[N06AX28, levomilnacipran, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Levomilnacipran.]
[C08EA02, bepridil, Linezolid may increase the hypotensive activities of Bepridil.]
[C02KX05, riociguat, Linezolid may increase the hypotensive activities of Riociguat.]
[L03AA14, lipegfilgrastim, Linezolid may increase the myelosuppressive activities of Lipegfilgrastim.]
[A10BJ03, lixisenatide, Linezolid may increase the hypoglycemic activities of Lixisenatide.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Linezolid.]
[C02KX04, macitentan, Linezolid may increase the hypotensive activities of Macitentan.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Linezolid is combined with Ibrutinib.]
[N06AX26, vortioxetine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Vortioxetine.]
[N03AF04, eslicarbazepine, The therapeutic efficacy of Eslicarbazepine can be decreased when used in combination with Linezolid.]
[S01EA03, apraclonidine, Linezolid may increase the alpha-adrenergic activities of Apraclonidine.]
[N03AG04, vigabatrin, The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Linezolid.]
[A10BK01, dapagliflozin, Linezolid may increase the orthostatic hypotensive activities of Dapagliflozin.]
[C01CA27, droxidopa, Linezolid may increase the hypertensive activities of Droxidopa.]
[C07AB04, acebutolol, The risk or severity of hypertension can be increased when Linezolid is combined with Acebutolol.]
[L04AA32, apremilast, The risk or severity of adverse effects can be increased when Linezolid is combined with Apremilast.]
[N07CA01, betahistine, The metabolism of Betahistine can be decreased when combined with Linezolid.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Linezolid.]
[S01ED02, betaxolol, Linezolid may increase the hypotensive activities of Betaxolol.]
[B01AE03, argatroban, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Argatroban.]
[C02CC01, bethanidine, Linezolid may increase the hypotensive activities of Bethanidine.]
[C10AB02, bezafibrate, Linezolid may increase the hepatotoxic activities of Bezafibrate.]
[A10BJ04, albiglutide, Linezolid may increase the hypoglycemic activities of Albiglutide.]
[L04AC11, siltuximab, The risk or severity of adverse effects can be increased when Linezolid is combined with Siltuximab.]
[B01AC26, vorapaxar, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Vorapaxar.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Vedolizumab.]
[A03BA03, hyoscyamine, Linezolid may increase the anticholinergic activities of Hyoscyamine.]
[B01AA07, acenocoumarol, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Acenocoumarol.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Linezolid is combined with Belinostat.]
[L01EM01, idelalisib, The risk or severity of adverse effects can be increased when Linezolid is combined with Idelalisib.]
[A10BK03, empagliflozin, Linezolid may increase the orthostatic hypotensive activities of Empagliflozin.]
[R03AC19, olodaterol, The risk or severity of hypertension can be increased when Linezolid is combined with Olodaterol.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Linezolid is combined with Peginterferon beta-1a.]
[N05AA04, acepromazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Acepromazine.]
[A10BJ05, dulaglutide, Linezolid may increase the hypoglycemic activities of Dulaglutide.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Linezolid is combined with Decitabine.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Linezolid is combined with Pirfenidone.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Linezolid is combined with Blinatumomab.]
[L01XK01, olaparib, The risk or severity of adverse effects can be increased when Linezolid is combined with Olaparib.]
[B01AA01, dicumarol, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Dicoumarol.]
[B01AF03, edoxaban, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Edoxaban.]
[N06AX11, mirtazapine, Linezolid may increase the serotonergic activities of Mirtazapine.]
[L04AC10, secukinumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Linezolid is combined with Palbociclib.]
[L01XH03, panobinostat, The risk or severity of adverse effects can be increased when Linezolid is combined with Panobinostat.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Linezolid.]
[B01AA11, tioclomarol, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Tioclomarol.]
[J05AF08, adefovir dipivoxil, The excretion of Adefovir dipivoxil can be decreased when combined with Linezolid.]
[A07DA06, eluxadoline, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Eluxadoline.]
[B01AC25, cangrelor, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Cangrelor.]
[N05AX16, brexpiprazole, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Brexpiprazole.]
[G02CX02, flibanserin, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Flibanserin.]
[N05AX15, cariprazine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Cariprazine.]
[A10BF01, acarbose, Linezolid may increase the hypoglycemic activities of Acarbose.]
[M02AA25, aceclofenac, The risk or severity of hypertension can be increased when Linezolid is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of hypertension can be increased when Linezolid is combined with Acemetacin.]
[S01EC01, acetazolamide, The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Linezolid.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Linezolid is combined with Insulin degludec.]
[N05AB07, acetophenazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Acetophenazine.]
[L01CX01, trabectedin, The risk or severity of adverse effects can be increased when Linezolid is combined with Trabectedin.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Mepolizumab.]
[J05AF13, tenofovir alafenamide, The excretion of Tenofovir alafenamide can be decreased when combined with Linezolid.]
[B01AC27, selexipag, Linezolid may increase the hypotensive activities of Selexipag.]
[A10BB31, acetohexamide, Linezolid may increase the hypoglycemic activities of Acetohexamide.]
[M01AE16, alminoprofen, The risk or severity of hypertension can be increased when Linezolid is combined with Alminoprofen.]
[N03AX23, brivaracetam, The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Linezolid.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Ixekizumab.]
[N04BC01, bromocriptine, Linezolid may increase the hypertensive activities of Bromocriptine.]
[N06AA19, amineptin, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Amineptine.]
[C08CA01, amlodipine, Linezolid may increase the hypotensive activities of Amlodipine.]
[C03CA02, bumetanide, The excretion of Bumetanide can be decreased when combined with Linezolid.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Bupivacaine.]
[C07AA19, bupranolol, Linezolid may increase the hypotensive activities of Bupranolol.]
[N07BC01, buprenorphine, The risk or severity of serotonin syndrome and opioid toxicity can be increased when Buprenorphine is combined with Linezolid.]
[N05BE01, buspirone, The risk or severity of hypertension can be increased when Linezolid is combined with Buspirone.]
[L01AB01, busulfan, The risk or severity of adverse effects can be increased when Linezolid is combined with Busulfan.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Linezolid is combined with Arsenic trioxide.]
[N02AF01, butorphanol, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Butorphanol.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Brodalumab.]
[A07EC04, balsalazide, The risk or severity of hypertension can be increased when Linezolid is combined with Balsalazide.]
[R03CC12, bambuterol, The risk or severity of hypertension can be increased when Linezolid is combined with Bambuterol.]
[L04AA36, ocrelizumab, Ocrelizumab may increase the immunosuppressive activities of Linezolid.]
[N07XX16, deutetrabenazine, The risk or severity of adverse effects can be increased when Linezolid is combined with Deutetrabenazine.]
[N02BF02, pregabalin, The therapeutic efficacy of Pregabalin can be decreased when used in combination with Linezolid.]
[N03AX30, beclamide, The therapeutic efficacy of Beclamide can be decreased when used in combination with Linezolid.]
[C09AA07, benazepril, Linezolid may increase the hypotensive activities of Benazepril.]
[A10BX06, benfluorex, Linezolid may increase the hypoglycemic activities of Benfluorex.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Oxybuprocaine.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Linezolid.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Linezolid is combined with Antilymphocyte immunoglobulin (horse).]
[L04AB02, infliximab, The risk or severity of adverse effects can be increased when Infliximab is combined with Linezolid.]
[N04BD03, safinamide, The risk or severity of serotonin syndrome can be increased when Safinamide is combined with Linezolid.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Sarilumab.]
[B01AF04, betrixaban, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Betrixaban.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Guselkumab.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Linezolid is combined with Capecitabine.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Linezolid is combined with Vorinostat.]
[C07AB07, bisoprolol, Linezolid may increase the hypotensive activities of Bisoprolol.]
[R03AC17, bitolterol, The risk or severity of hypertension can be increased when Linezolid is combined with Bitolterol.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Linezolid.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Linezolid.]
[V03AF08, palifermin, The therapeutic efficacy of Palifermin can be decreased when used in combination with Linezolid.]
[C01DX19, nesiritide, Linezolid may increase the orthostatic hypotensive activities of Nesiritide.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Linezolid is combined with Bromperidol.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Linezolid is combined with Budesonide.]
[C04AX20, buflomedil, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Buflomedil.]
[M01AB07, bumadizone, The risk or severity of hypertension can be increased when Linezolid is combined with Bumadizone.]
[N06AA15, butriptyline, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Butriptyline.]
[A10BJ06, semaglutide, Linezolid may increase the hypoglycemic activities of Semaglutide.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Capsaicin.]
[A10BK04, ertugliflozin, Linezolid may increase the hypoglycemic activities of Ertugliflozin.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Linezolid.]
[N03AF01, carbamazepine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Linezolid.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Linezolid.]
[C07AG02, carvedilol, Linezolid may increase the hypotensive activities of Carvedilol.]
[N03AX24, cannabidiol, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Cannabidiol.]
[L04AA37, baricitinib, The serum concentration of Baricitinib can be increased when it is combined with Linezolid.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Linezolid.]
[C07AB08, celiprolol, The risk or severity of hypertension can be increased when Linezolid is combined with Celiprolol.]
[N03AX17, stiripentol, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Linezolid.]
[J01AA13, eravacycline, The metabolism of Eravacycline can be decreased when combined with Linezolid.]
[A10BB06, carbutamide, Linezolid may increase the hypoglycemic activities of Carbutamide.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Chloroprocaine.]
[M01AC05, lornoxicam, The risk or severity of hypertension can be increased when Linezolid is combined with Lornoxicam.]
[L04AA39, emapalumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Linezolid.]
[N07XX05, amifampridine, The risk or severity of seizure can be increased when Linezolid is combined with Amifampridine.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Ravulizumab.]
[C09AA08, cilazapril, Linezolid may increase the hypotensive activities of Cilazapril.]
[B01AX07, caplacizumab, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Caplacizumab.]
[B01AC23, cilostazol, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Cilostazol.]
[A03FA08, cinitapride, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Cinitapride.]
[N06AX27, esketamine, The risk or severity of hypertension can be increased when Esketamine is combined with Linezolid.]
[L04AA42, siponimod, The risk or severity of adverse effects can be increased when Linezolid is combined with Siponimod.]
[N06BA14, solriamfetol, The risk or severity of hypertension can be increased when Solriamfetol is combined with Linezolid.]
[N06AX29, brexanolone, The therapeutic efficacy of Brexanolone can be decreased when used in combination with Linezolid.]
[N05BA09, clobazam, The therapeutic efficacy of Clobazam can be decreased when used in combination with Linezolid.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Linezolid is combined with Cloprednol.]
[C09CA06, candesartan, Linezolid may increase the hypotensive activities of Candesartan.]
[L04AB01, etanercept, The risk or severity of adverse effects can be increased when Etanercept is combined with Linezolid.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Linezolid is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Risankizumab.]
[J01DC04, cefaclor, The excretion of Cefaclor can be decreased when combined with Linezolid.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Linezolid.]
[N05AA06, cyamemazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Cyamemazine.]
[J01DC07, cefotiam, The excretion of Cefotiam can be decreased when combined with Linezolid.]
[C03BX03, cicletanine, Linezolid may increase the hypotensive activities of Cicletanine.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Linezolid.]
[M03BX08, cyclobenzaprine, Cyclobenzaprine may increase the serotonergic activities of Linezolid.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Linezolid is combined with Upadacitinib.]
[C03AA09, cyclothiazide, Linezolid may increase the hypotensive activities of Cyclothiazide.]
[G04BE04, yohimbine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Yohimbine.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Linezolid is combined with Insulin pork.]
[J01DB01, cephalexin, The excretion of Cephalexin can be decreased when combined with Linezolid.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Linezolid.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Linezolid is combined with Deflazacort.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Linezolid.]
[N02CC08, lasmiditan, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Lasmiditan.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Linezolid is combined with Diroximel fumarate.]
[N03AX25, cenobamate, The therapeutic efficacy of Cenobamate can be decreased when used in combination with Linezolid.]
[N02AX03, dezocine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Dezocine.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Teprotumumab.]
[N05AD10, lumateperone, The risk or severity of adverse effects can be increased when Linezolid is combined with Lumateperone.]
[N02CC07, frovatriptan, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Frovatriptan.]
[G04CB02, dutasteride, The risk or severity of hypertension can be increased when Linezolid is combined with Dutasteride.]
[L04AA38, ozanimod, The risk or severity of adverse effects can be increased when Linezolid is combined with Ozanimod.]
[N02AA08, dihydrocodeine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Dihydrocodeine.]
[N02CC06, eletriptan, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Eletriptan.]
[M01AH02, rofecoxib, The risk or severity of hypertension can be increased when Rofecoxib is combined with Linezolid.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Linezolid.]
[C08CA16, clevidipine, Linezolid may increase the orthostatic hypotensive activities of Clevidipine.]
[C01BD07, dronedarone, The risk or severity of hypertension can be increased when Linezolid is combined with Dronedarone.]
[N03AG02, dipropylacetamide, The therapeutic efficacy of Valpromide can be decreased when used in combination with Linezolid.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Linezolid.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Linezolid.]
[C02AA06, methoserpidine, Linezolid may increase the hypotensive activities of Methoserpidine.]
[N04BX04, opicapone, Linezolid may increase the orthostatic hypotensive activities of Opicapone.]
[C01CA14, dopexamine, The risk or severity of hypertension can be increased when Linezolid is combined with Dopexamine.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Linezolid is combined with Fluprednidene.]
[M01AC04, droxicam, The risk or severity of hypertension can be increased when Linezolid is combined with Droxicam.]
[L01EX22, selpercatinib, The risk or severity of hypertension can be increased when Linezolid is combined with Selpercatinib.]
[B01AE02, lepirudin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Lepirudin.]
[M02AA27, dexketoprofen, The risk or severity of hypertension can be increased when Linezolid is combined with Dexketoprofen.]
[N05CM02, chlormethiazole, The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Linezolid.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Linezolid is combined with Inebilizumab.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Dyclonine.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Linezolid is combined with Stepronin.]
[C08CA17, levamlodipine, Linezolid may increase the hypotensive activities of Levamlodipine.]
[L04AC19, satralizumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Oliceridine.]
[C03AA04, chlorothiazide, Linezolid may increase the hypotensive activities of Chlorothiazide.]
[R06AB04, chlorpheniramine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Chlorpromazine.]
[A10BB02, chlorpropamide, Linezolid may increase the hypoglycemic activities of Chlorpropamide.]
[N05AF03, chlorprothixene, The risk or severity of adverse effects can be increased when Linezolid is combined with Chlorprothixene.]
[C03BA04, chlorthalidone, Linezolid may increase the hypotensive activities of Chlorthalidone.]
[N02BA07, ethenzamide, The risk or severity of hypertension can be increased when Linezolid is combined with Ethenzamide.]
[N06BX18, vinpocetine, The therapeutic efficacy of Vinpocetine can be decreased when used in combination with Linezolid.]
[M01AB08, etodolac, The risk or severity of hypertension can be increased when Linezolid is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of hypertension can be increased when Linezolid is combined with Etofenamate.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Linezolid is combined with Fludarabine.]
[L01FX21, naxitamab, The risk or severity of hypertension can be increased when Linezolid is combined with Naxitamab.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Linezolid is combined with Voclosporin.]
[C01DX22, vericiguat, Linezolid may increase the orthostatic hypotensive activities of Vericiguat.]
[N03AX10, felbamate, The therapeutic efficacy of Felbamate can be decreased when used in combination with Linezolid.]
[M01AE05, fenbufen, The risk or severity of hypertension can be increased when Linezolid is combined with Fenbufen.]
[C01CA19, fenoldopam, Linezolid may increase the hypotensive activities of Fenoldopam.]
[N06BA08, fenozolone, The risk or severity of hypertension can be increased when Linezolid is combined with Fenozolone.]
[G04CB01, finasteride, The risk or severity of hypertension can be increased when Linezolid is combined with Finasteride.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Linezolid.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Linezolid.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Linezolid.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Linezolid.]
[R03CC15, formoterol, The risk or severity of adverse effects can be increased when Linezolid is combined with Formoterol.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Linezolid is combined with Insulin human.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Linezolid is combined with Ponesimod.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Trichloroethylene is combined with Linezolid.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Linezolid.]
[H04AA02, dasiglucagon, Linezolid may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The excretion of Cimetidine can be decreased when combined with Linezolid.]
[N02BF01, gabapentin, The therapeutic efficacy of Gabapentin can be decreased when used in combination with Linezolid.]
[L01XA01, cisplatin, The risk or severity of adverse effects can be increased when Cisplatin is combined with Linezolid.]
[N06AB04, citalopram, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Citalopram.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Linezolid is combined with Pegcetacoplan.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Linezolid is combined with Belumosudil.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Anifrolumab.]
[R06AA04, clemastine, Linezolid may increase the anticholinergic activities of Clemastine.]
[M01AG01, mefenamic acid, The risk or severity of hypertension can be increased when Linezolid is combined with Mefenamic acid.]
[A10BB12, glimepiride, Linezolid may increase the hypoglycemic activities of Glimepiride.]
[A10BB08, gliquidone, Linezolid may increase the hypoglycemic activities of Gliquidone.]
[R03CC13, clenbuterol, The risk or severity of hypertension can be increased when Linezolid is combined with Clenbuterol.]
[N06AX25, St. John's wort extract, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Linezolid is combined with Ropeginterferon alfa-2b.]
[B01AD11, tenecteplase, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Tenecteplase.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Levobupivacaine.]
[N06AA04, clomipramine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Clomipramine.]
[N03AE01, clonazepam, The therapeutic efficacy of Clonazepam can be decreased when used in combination with Linezolid.]
[S01EA04, clonidine, Linezolid may increase the hypertensive activities of Clonidine.]
[J05AH02, oseltamivir, The excretion of Oseltamivir can be decreased when combined with Linezolid.]
[A10BX16, tirzepatide, Linezolid may increase the hypoglycemic activities of Tirzepatide.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Linezolid is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Linezolid is combined with Deucravacitinib.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Linezolid is combined with Clothiapine.]
[A04AA01, ondansetron, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Granisetron.]
[N05AH02, clozapine, The risk or severity of neutropenia can be increased when Linezolid is combined with Clozapine.]
[A10BX01, guar gum, Linezolid may increase the hypoglycemic activities of Guar gum.]
[A10BK06, sotagliflozin, Linezolid may increase the hypoglycemic activities of Sotagliflozin.]
[S02DA02, cocaine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Cocaine.]
[C02KB01, metyrosine, Linezolid may increase the hypotensive activities of Metyrosine.]
[L04AC21, bimekizumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of hypertension can be increased when Linezolid is combined with Proquazone.]
[R05DA04, codeine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Codeine.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Linezolid is combined with Leflunomide.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Desflurane is combined with Linezolid.]
[C04AX28, ifenprodil, The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Linezolid.]
[A10BX03, nateglinide, Linezolid may increase the hypoglycemic activities of Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of hypertension can be increased when Linezolid is combined with Imidazole salicylate.]
[H01AC03, mecasermin, Linezolid may increase the hypoglycemic activities of Mecasermin.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Linezolid is combined with Nelarabine.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Linezolid is combined with Insulin glargine.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Linezolid is combined with Ciclesonide.]
[B01AC10, indobufen, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Indobufen.]
[M01AH03, valdecoxib, The risk or severity of hypertension can be increased when Valdecoxib is combined with Linezolid.]
[A03AX10, isometheptene, Linezolid may increase the sympathomimetic activities of Isometheptene.]
[N02CC05, almotriptan, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Almotriptan.]
[M01AH04, parecoxib, The risk or severity of hypertension can be increased when Linezolid is combined with Parecoxib.]
[B01AB12, bemiparin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Bemiparin.]
[S01AD03, acyclovir, The excretion of Acyclovir can be decreased when combined with Linezolid.]
[M01AA06, kebuzone, The risk or severity of hypertension can be increased when Linezolid is combined with Kebuzone.]
[L01EA01, imatinib, The risk or severity of adverse effects can be increased when Linezolid is combined with Imatinib.]
[C08CA09, lacidipine, Linezolid may increase the hypotensive activities of Lacidipine.]
[N03AX09, lamotrigine, The therapeutic efficacy of Lamotrigine can be decreased when used in combination with Linezolid.]
[N07BC04, lofexidine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Lofexidine.]
[M01AB09, lonazolac, The risk or severity of hypertension can be increased when Linezolid is combined with Lonazolac.]
[M02AA31, loxoprofen, The risk or severity of hypertension can be increased when Linezolid is combined with Loxoprofen.]
[C09AA03, lisinopril, Linezolid may increase the hypotensive activities of Lisinopril.]
[C08CA11, manidipine, Linezolid may increase the hypotensive activities of Manidipine.]
[A08AA09, mefenorex, The risk or severity of hypertension can be increased when Linezolid is combined with Mefenorex.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Linezolid is combined with Meprednisone.]
[R06AD07, mequitazine, Linezolid may increase the anticholinergic activities of Mequitazine.]
[R03CB02, methoxyphenamine, The risk or severity of hypertension can be increased when Linezolid is combined with Methoxyphenamine.]
[C03DA04, eplerenone, Linezolid may increase the hypotensive activities of Eplerenone.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Linezolid is combined with Melperone.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Linezolid.]
[C03AA07, cyclopenthiazide, Linezolid may increase the hypotensive activities of Cyclopenthiazide.]
[A10BF02, miglitol, Linezolid may increase the hypoglycemic activities of Miglitol.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Linezolid.]
[L01AA01, cyclophosphamide, The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Linezolid.]
[N06AX07, minaprine, The risk or severity of serotonin syndrome can be increased when Minaprine is combined with Linezolid.]
[S01XA18, cyclosporine, Linezolid may increase the immunosuppressive activities of Cyclosporine.]
[N06AG02, moclobemide, The risk or severity of serotonin syndrome can be increased when Moclobemide is combined with Linezolid.]
[R06AX02, cyproheptadine, Linezolid may increase the anticholinergic activities of Cyproheptadine.]
[C09AA13, moexipril, Linezolid may increase the hypotensive activities of Moexipril.]
[C10AA07, rosuvastatin, The excretion of Rosuvastatin can be decreased when combined with Linezolid.]
[M02AA02, mofebutazone, The risk or severity of hypertension can be increased when Linezolid is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of hypertension can be increased when Linezolid is combined with Morniflumate.]
[C03XA02, conivaptan, Linezolid may increase the orthostatic hypotensive activities of Conivaptan.]
[C02AC05, moxonidine, Linezolid may increase the hypotensive activities of Moxonidine.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Linezolid is combined with Cytarabine.]
[M01AH05, etoricoxib, The risk or severity of hypertension can be increased when Linezolid is combined with Etoricoxib.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Linezolid is combined with Dacarbazine.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Linezolid is combined with Dactinomycin.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Linezolid is combined with Daunorubicin.]
[C02CC04, debrisoquin, Linezolid may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, Linezolid may increase the orthostatic hypotensive activities of Nabilone.]
[M01AX01, nabumetone, The risk or severity of hypertension can be increased when Nabumetone is combined with Linezolid.]
[C07AB12, nebivolol, Linezolid may increase the hypotensive activities of Nebivolol.]
[N06AX06, nefazodone, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Nefazodone.]
[C01DX16, nicorandil, Linezolid may increase the hypotensive activities of Nicorandil.]
[N03AG06, tiagabine, The therapeutic efficacy of Tiagabine can be decreased when used in combination with Linezolid.]
[C01CA23, theodrenaline, The risk or severity of hypertension can be increased when Linezolid is combined with Theodrenaline.]
[M03AC11, cisatracurium, Linezolid may increase the neuromuscular blocking activities of Cisatracurium.]
[C01CA05, norfenefrine, The risk or severity of hypertension can be increased when Linezolid is combined with Norfenefrine.]
[R05DA06, normethadone, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Normethadone.]
[B01AX05, fondaparinux, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Fondaparinux.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Linezolid.]
[N06AB10, escitalopram, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Escitalopram.]
[G04BD08, solifenacin, The risk or severity of hypertension can be increased when Linezolid is combined with Solifenacin.]
[A07EC03, olsalazine, The risk or severity of hypertension can be increased when Linezolid is combined with Olsalazine.]
[N06AA01, desipramine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Desipramine.]
[H01BA02, desmopressin, The risk or severity of hypertension can be increased when Desmopressin is combined with Linezolid.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Desoximetasone is combined with Linezolid.]
[C09XA02, aliskiren, Linezolid may increase the hypotensive activities of Aliskiren.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Linezolid.]
[M01AE12, oxaprozin, The risk or severity of hypertension can be increased when Linezolid is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Linezolid.]
[S03BA01, dexamethasone, The risk or severity of adverse effects can be increased when Linezolid is combined with Dexamethasone.]
[A08AA04, dexfenfluramine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Dexfenfluramine.]
[L04AB04, adalimumab, The risk or severity of adverse effects can be increased when Adalimumab is combined with Linezolid.]
[N06BA02, dextroamphetamine, The risk or severity of hypertension can be increased when Linezolid is combined with Amphetamine.]
[R05DA09, dextromethorphan, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Dextromethorphan.]
[N03AC01, paramethadione, The therapeutic efficacy of Paramethadione can be decreased when used in combination with Linezolid.]
[N02AC01, dextromoramide, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Dextromoramide.]
[N06AB05, paroxetine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Paroxetine.]
[B01AC04, clopidogrel, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Clopidogrel.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Diamorphine is combined with Linezolid.]
[N05BA01, diazepam, The therapeutic efficacy of Diazepam can be decreased when used in combination with Linezolid.]
[N03AX07, phenacemide, The therapeutic efficacy of Phenacemide can be decreased when used in combination with Linezolid.]
[V03AH01, diazoxide, Linezolid may increase the hypotensive activities of Diazoxide.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Phenol.]
[N03AD02, phensuximide, The therapeutic efficacy of Phensuximide can be decreased when used in combination with Linezolid.]
[N06AA08, dibenzepin, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Cinchocaine.]
[R05DA08, pholcodine, Pholcodine may increase the serotonergic activities of Linezolid.]
[S01EC02, dichlorphenamide, Linezolid may increase the orthostatic hypotensive activities of Diclofenamide.]
[S01BC03, diclofenac, The risk or severity of hypertension can be increased when Diclofenac is combined with Linezolid.]
[J05AF03, zalcitabine, The excretion of Zalcitabine can be decreased when combined with Linezolid.]
[J05AF02, didanosine, The excretion of Didanosine can be decreased when combined with Linezolid.]
[C02DG01, pinacidil, Linezolid may increase the hypotensive activities of Pinacidil.]
[A10BG03, pioglitazone, Linezolid may increase the hypoglycemic activities of Pioglitazone.]
[N05AD05, pipamperone, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Pipamperone.]
[L01DC04, ixabepilone, The risk or severity of adverse effects can be increased when Linezolid is combined with Ixabepilone.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Linezolid is combined with Pirarubicin.]
[R03CC07, pirbuterol, The risk or severity of hypertension can be increased when Linezolid is combined with Pirbuterol.]
[A08AA03, diethylpropion, The risk or severity of hypertension can be increased when Linezolid is combined with Diethylpropion.]
[C08CA03, isradipine, Linezolid may increase the hypotensive activities of Isradipine.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Linezolid is combined with Difluocortolone.]
[N02BA11, diflunisal, The risk or severity of hypertension can be increased when Linezolid is combined with Diflunisal.]
[C02DB01, dihydralazine, Linezolid may increase the hypotensive activities of Dihydralazine.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Linezolid.]
[C04AE04, dihydroergocristine, The risk or severity of hypertension can be increased when Linezolid is combined with Dihydroergocristine.]
[N02CA01, dihydroergotamine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Dihydroergotamine.]
[N02AA03, hydromorphone, Linezolid may increase the serotonergic activities of Hydromorphone.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Linezolid.]
[B01AC21, treprostinil, Linezolid may increase the hypotensive activities of Treprostinil.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Pramocaine.]
[C08DB01, diltiazem, Linezolid may increase the hypotensive activities of Diltiazem.]
[R03CC08, procaterol, The risk or severity of hypertension can be increased when Linezolid is combined with Procaterol.]
[N03AG05, progabide, The therapeutic efficacy of Progabide can be decreased when used in combination with Linezolid.]
[N02BB04, propyphenazone, The risk or severity of hypertension can be increased when Linezolid is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of hypertension can be increased when Linezolid is combined with Proglumetacin.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Linezolid.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Diphenhydramine.]
[A07DA01, diphenoxylate, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Diphenoxylate.]
[C09AA06, quinapril, The excretion of Quinapril can be decreased when combined with Linezolid.]
[B01AC07, dipyridamole, Linezolid may increase the orthostatic hypotensive activities of Dipyridamole.]
[N06BA11, dexmethylphenidate, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Dexmethylphenidate.]
[B01AD10, drotrecogin alfa, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Drotrecogin alfa.]
[N06AA23, quinupramine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Quinupramine.]
[A03FA02, cisapride, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Cisapride.]
[C09AA05, ramipril, Linezolid may increase the hypotensive activities of Ramipril.]
[S01XA23, sirolimus, The risk or severity of adverse effects can be increased when Linezolid is combined with Sirolimus.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Linezolid is combined with Remoxipride.]
[R03CC14, reproterol, The risk or severity of hypertension can be increased when Linezolid is combined with Reproterol.]
[C01BA03, disopyramide, Linezolid may increase the hypoglycemic activities of Disopyramide.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Natalizumab.]
[N07XX02, riluzole, The therapeutic efficacy of Riluzole can be decreased when used in combination with Linezolid.]
[N05AX08, risperidone, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Risperidone.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Linezolid.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Ropivacaine.]
[L01EX01, sunitinib, The risk or severity of adverse effects can be increased when Linezolid is combined with Sunitinib.]
[L01XG01, bortezomib, The risk or severity of adverse effects can be increased when Bortezomib is combined with Linezolid.]
[G04BE08, tadalafil, Linezolid may increase the hypotensive activities of Tadalafil.]
[S01BC05, ketorolac, The risk or severity of hypertension can be increased when Ketorolac is combined with Linezolid.]
[C02KX02, ambrisentan, Linezolid may increase the hypotensive activities of Ambrisentan.]
[N02BA06, salsalate, The risk or severity of hypertension can be increased when Linezolid is combined with Salsalate.]
[R03AC12, salmeterol, The risk or severity of hypertension can be increased when Linezolid is combined with Salmeterol.]
[C01CA07, dobutamine, The risk or severity of hypertension can be increased when Linezolid is combined with Dobutamine.]
[A03FA03, domperidone, The risk or severity of QTc prolongation, torsade de pointes, and cardiotoxicity can be increased when Linezolid is combined with Domperidone.]
[C01CA04, dopamine, The risk or severity of hypertension can be increased when Linezolid is combined with Dopamine.]
[N06AA16, dothiepin, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Dosulepin.]
[R07AB01, doxapram, Linezolid may increase the hypertensive activities of Doxapram.]
[N06AA12, doxepin, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Doxepin.]
[L01DB01, doxorubicin, The risk or severity of adverse effects can be increased when Linezolid is combined with Doxorubicin.]
[R06AA09, doxylamine, Linezolid may increase the anticholinergic activities of Doxylamine.]
[N06AB06, sertraline, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Sertraline.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Sevoflurane is combined with Linezolid.]
[N05AD08, droperidol, The risk or severity of adverse effects can be increased when Linezolid is combined with Droperidol.]
[A08AA10, sibutramine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Sibutramine.]
[C09AA11, spirapril, Linezolid may increase the hypotensive activities of Spirapril.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Linezolid is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Sumatriptan.]
[C07AB13, talinolol, Linezolid may increase the hypotensive activities of Talinolol.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Linezolid is combined with Corticotropin.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Linezolid.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Linezolid is combined with Temozolomide.]
[M01AC02, tenoxicam, The risk or severity of hypertension can be increased when Tenoxicam is combined with Linezolid.]
[G04CA03, terazosin, Linezolid may increase the hypotensive activities of Terazosin.]
[S01GA02, tetrahydrozoline, The risk or severity of hypertension can be increased when Linezolid is combined with Tetryzoline.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Linezolid is combined with Thiopropazate.]
[N06AX14, tianeptine, The risk or severity of adverse effects can be increased when Tianeptine is combined with Linezolid.]
[C09AA02, enalapril, Linezolid may increase the hypotensive activities of Enalapril.]
[M01AG02, tolfenamic acid, The risk or severity of hypertension can be increased when Linezolid is combined with Tolfenamic acid.]
[N06AG03, toloxatone, The risk or severity of serotonin syndrome can be increased when Toloxatone is combined with Linezolid.]
[N06BA09, atomoxetine, The risk or severity of adverse effects can be increased when Linezolid is combined with Atomoxetine.]
[N03AX11, topiramate, The therapeutic efficacy of Topiramate can be decreased when used in combination with Linezolid.]
[C03CA04, torsemide, Linezolid may increase the hypotensive activities of Torasemide.]
[R01AA09, tramazoline, The risk or severity of hypertension can be increased when Linezolid is combined with Tramazoline.]
[C09AA10, trandolapril, Linezolid may increase the hypotensive activities of Trandolapril.]
[B01AC18, triflusal, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Triflusal.]
[H02CA01, trilostane, The risk or severity of adverse effects can be increased when Linezolid is combined with Trilostane.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Linezolid is combined with Trofosfamide.]
[C05CA04, troxerutin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Troxerutin.]
[R03CC11, tulobuterol, The risk or severity of hypertension can be increased when Linezolid is combined with Tulobuterol.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Linezolid.]
[C02CA06, urapidil, Linezolid may increase the hypotensive activities of Urapidil.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Linezolid is combined with Veralipride.]
[L01CA04, vinorelbine, The risk or severity of adverse effects can be increased when Vinorelbine is combined with Linezolid.]
[S01FB02, ephedrine, The risk or severity of hypertension can be increased when Linezolid is combined with Ephedrine.]
[N06AX16, venlafaxine, Linezolid may increase the serotonergic activities of Venlafaxine.]
[C01CX07, xamoterol, The risk or severity of hypertension can be increased when Linezolid is combined with Xamoterol.]
[S01GA03, xylometazoline, Linezolid may increase the hypertensive activities of Xylometazoline.]
[C08CA12, mepirodipine, Linezolid may increase the orthostatic hypotensive activities of Barnidipine.]
[S01EA01, epinephrine, The risk or severity of hypertension can be increased when Linezolid is combined with Epinephrine.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Linezolid.]
[C09AA15, zofenopril, Linezolid may increase the hypotensive activities of Zofenopril.]
[M01AB04, zomepirac, The risk or severity of hypertension can be increased when Linezolid is combined with Zomepirac.]
[N03AX15, zonisamide, The therapeutic efficacy of Zonisamide can be decreased when used in combination with Linezolid.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Linezolid is combined with Insulin glulisine.]
[N05AX11, zotepine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Zotepine.]
[B01AD03, anistreplase, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Anistreplase.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Linezolid is combined with Carboplatin.]
[C02AC02, guanfacine, Linezolid may increase the hypotensive activities of Guanfacine.]
[B01AC11, iloprost, Linezolid may increase the orthostatic hypotensive activities of Iloprost.]
[C01BG01, moricizine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Moricizine.]
[G02AB03, ergonovine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Ergometrine.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Ergoloid mesylate.]
[N02CA02, ergotamine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Ergotamine.]
[N05CD04, estazolam, The therapeutic efficacy of Estazolam can be decreased when used in combination with Linezolid.]
[G03CA03, estradiol, The excretion of Estradiol can be decreased when combined with Linezolid.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Linezolid is combined with Estramustine.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Linezolid.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Linezolid is combined with Fluticasone furoate.]
[R03BA05, fluticasone, The risk or severity of adverse effects can be increased when Linezolid is combined with Fluticasone.]
[C01CA15, gepefrine, The risk or severity of hypertension can be increased when Linezolid is combined with Gepefrine.]
[V03AF05, amifostine, Linezolid may increase the orthostatic hypotensive activities of Amifostine.]
[N03AD01, ethosuximide, The therapeutic efficacy of Ethosuximide can be decreased when used in combination with Linezolid.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be decreased when used in combination with Linezolid.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Meloxicam.]
[S01XA06, ethylmorphine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Ethylmorphine.]
[C01CA01, etilefrine, The risk or severity of hypertension can be increased when Linezolid is combined with Etilefrine.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Etidocaine.]
[N01AX07, etomidate, The risk or severity of hypertension can be increased when Etomidate is combined with Linezolid.]
[L01CB01, etoposide, The risk or severity of adverse effects can be increased when Linezolid is combined with Etoposide.]
[N05AE03, sertindole, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Sertindole.]
[L04AD02, tacrolimus, Tacrolimus may increase the immunosuppressive activities of Linezolid.]
[N06AX12, bupropion, The risk or severity of adverse effects can be increased when Linezolid is combined with Bupropion.]
[N06AB08, fluvoxamine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Fluvoxamine.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Linezolid.]
[C10AA03, pravastatin, The excretion of Pravastatin can be decreased when combined with Linezolid.]
[B05AA05, dextran, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Dextran.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Linezolid.]
[A02BA03, famotidine, The excretion of Famotidine can be decreased when combined with Linezolid.]
[A16AA01, levocarnitine, The excretion of Levocarnitine can be decreased when combined with Linezolid.]
[C08CA02, felodipine, Linezolid may increase the hypotensive activities of Felodipine.]
[N03AX26, fenfluramine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Fenfluramine.]
[M01AE04, fenoprofen, The risk or severity of hypertension can be increased when Fenoprofen is combined with Linezolid.]
[R03CC04, fenoterol, The risk or severity of hypertension can be increased when Linezolid is combined with Fenoterol.]
[N02AB03, fentanyl, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Fentanyl.]
[R03CC02, albuterol, The risk or severity of hypertension can be increased when Linezolid is combined with Salbutamol.]
[B01AD05, plasmin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Fibrinolysin.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Linezolid is combined with Clofarabine.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Linezolid.]
[N02BG04, floctafenine, The risk or severity of hypertension can be increased when Linezolid is combined with Floctafenine.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Linezolid is combined with Flucytosine.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Linezolid is combined with Fludrocortisone.]
[N07CA03, flunarizine, The therapeutic efficacy of Flunarizine can be decreased when used in combination with Linezolid.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Linezolid is combined with Fluocinonide.]
[N06AA14, melitracen, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Melitracen.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Linezolid is combined with Fluocortolone.]
[V03AZ01, ethanol, The risk or severity of adverse effects can be increased when Ethanol is combined with Linezolid.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Linezolid.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Linezolid.]
[L01BC02, fluorouracil, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Linezolid.]
[N06AB03, fluoxetine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Fluoxetine.]
[N05AF01, flupenthixol, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Flupentixol.]
[N05AB02, fluphenazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Fluphenazine.]
[S01BC04, flurbiprofen, The risk or severity of hypertension can be increased when Linezolid is combined with Flurbiprofen.]
[N05AG01, fluspirilene, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Fluspirilene.]
[N06BX17, adrafinil, The risk or severity of hypertension can be increased when Linezolid is combined with Adrafinil.]
[G01AX06, furazolidone, The risk or severity of serotonin syndrome can be increased when Furazolidone is combined with Linezolid.]
[C03CA01, furosemide, Linezolid may increase the hypotensive activities of Furosemide.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Linezolid is combined with Amisulpride.]
[N03AA04, barbexaclone, The therapeutic efficacy of Barbexaclone can be decreased when used in combination with Linezolid.]
[N06AX08, bifemelane, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Bifemelane.]
[L01EA02, dasatinib, The risk or severity of adverse effects can be increased when Linezolid is combined with Dasatinib.]
[N04BC06, cabergoline, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Cabergoline.]
[A10BJ02, liraglutide, Linezolid may increase the hypoglycemic activities of Liraglutide.]
[N03AD03, methsuximide, The therapeutic efficacy of Methsuximide can be decreased when used in combination with Linezolid.]
[N01AH02, alfentanil, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Alfentanil.]
[A10BB01, glyburide, Linezolid may increase the hypoglycemic activities of Glyburide.]
[A10BB09, gliclazide, Linezolid may increase the hypoglycemic activities of Gliclazide.]
[A10BB07, glipizide, Linezolid may increase the hypoglycemic activities of Glipizide.]
[N05CM18, dexmedetomidine, Linezolid may increase the orthostatic hypotensive activities of Dexmedetomidine.]
[C05AE01, nitroglycerin, Linezolid may increase the hypotensive activities of Nitroglycerin.]
[C02CA04, doxazosin, Linezolid may increase the hypotensive activities of Doxazosin.]
[L01EX02, sorafenib, The risk or severity of adverse effects can be increased when Sorafenib is combined with Linezolid.]
[C07AB09, esmolol, Linezolid may increase the hypotensive activities of Esmolol.]
[B01AA12, fluindione, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Fluindione.]
[C09AA09, fosinopril, Linezolid may increase the hypotensive activities of Fosinopril.]
[S01EX01, guanethidine, Linezolid may increase the hypotensive activities of Guanethidine.]
[N05AD01, haloperidol, The risk or severity of adverse effects can be increased when Linezolid is combined with Haloperidol.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Halothane is combined with Linezolid.]
[N05AH04, quetiapine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Quetiapine.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Linezolid is combined with Insulin aspart.]
[L01CE02, irinotecan, The risk or severity of adverse effects can be increased when Linezolid is combined with Irinotecan.]
[M04AA01, allopurinol, The risk or severity of adverse effects can be increased when Allopurinol is combined with Linezolid.]
[C09CA01, losartan, Linezolid may increase the hypotensive activities of Losartan.]
[S01XA14, heparin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Heparin.]
[A07EC02, mesalamine, The risk or severity of hypertension can be increased when Mesalazine is combined with Linezolid.]
[L01XX03, altretamine, Altretamine may increase the orthostatic hypotensive activities of Linezolid.]
[N05CA16, hexobarbital, The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Linezolid.]
[R03CC05, hexoprenaline, The risk or severity of hypertension can be increased when Linezolid is combined with Hexoprenaline.]
[C08CA10, nilvadipine, Linezolid may increase the hypotensive activities of Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Nimesulide.]
[C09AA04, perindopril, Linezolid may increase the hypotensive activities of Perindopril.]
[C02DB02, hydralazine, Linezolid may increase the hypotensive activities of Hydralazine.]
[C03AA03, hydrochlorothiazide, The excretion of Hydrochlorothiazide can be decreased when combined with Linezolid.]
[R05DA03, hydrocodone, Linezolid may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[S02BA01, hydrocortisone, The excretion of Hydrocortisone can be decreased when combined with Linezolid.]
[C03AA02, hydroflumethiazide, Linezolid may increase the hypotensive activities of Hydroflumethiazide.]
[G04BD06, propiverine, The risk or severity of hypertension can be increased when Linezolid is combined with Propiverine.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Linezolid is combined with Hydroxychloroquine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Linezolid is combined with Prothipendyl.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Linezolid is combined with Hydroxyurea.]
[C02AC06, rilmenidine, Linezolid may increase the hypotensive activities of Rilmenidine.]
[R02AX02, ibuprofen, The risk or severity of hypertension can be increased when Linezolid is combined with Ibuprofen.]
[B05CB02, sodium citrate, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Sodium citrate.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Linezolid is combined with Idarubicin.]
[L01AA06, ifosfamide, The risk or severity of adverse effects can be increased when Linezolid is combined with Ifosfamide.]
[N01AH03, sufentanil, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Sufentanil.]
[N06AA02, imipramine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Imipramine.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Linezolid is combined with Paclitaxel.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Linezolid is combined with Tixocortol.]
[M03BX02, tizanidine, Linezolid may increase the orthostatic hypotensive activities of Tizanidine.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Linezolid is combined with Topotecan.]
[C03BA11, indapamide, Linezolid may increase the hypotensive activities of Indapamide.]
[S01BC01, indomethacin, The risk or severity of adverse effects can be increased when Indomethacin is combined with Linezolid.]
[C02CA02, indoramin, Linezolid may increase the hypotensive activities of Indoramin.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Linezolid.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Linezolid.]
[N06AX17, milnacipran, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Milnacipran.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Eculizumab.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Articaine.]
[A10BH01, sitagliptin, The excretion of Sitagliptin can be decreased when combined with Linezolid.]
[A10BH02, vildagliptin, Linezolid may increase the hypoglycemic activities of Vildagliptin.]
[L01XX35, anagrelide, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Anagrelide.]
[C07AA01, alprenolol, Linezolid may increase the hypotensive activities of Alprenolol.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Linezolid.]
[J05AF04, stavudine, The excretion of Stavudine can be decreased when combined with Linezolid.]
[N06AA13, iprindole, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Iprindole.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Linezolid.]
[N06AF05, iproniazid, The risk or severity of serotonin syndrome can be increased when Iproniazid is combined with Linezolid.]
[N05AA07, chlorproethazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Chlorproethazine.]
[N06AF01, isocarboxazid, The risk or severity of serotonin syndrome can be increased when Isocarboxazid is combined with Linezolid.]
[R03CC06, isoetharine, The risk or severity of hypertension can be increased when Isoetharine is combined with Linezolid.]
[C09AA16, imidapril, Linezolid may increase the hypotensive activities of Imidapril.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Linezolid.]
[J04AC01, isoniazid, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Isoniazid.]
[R03CB01, isoproterenol, The risk or severity of hypertension can be increased when Linezolid is combined with Isoprenaline.]
[A10BJ01, exenatide, Linezolid may increase the hypoglycemic activities of Exenatide.]
[C01DA14, isosorbide mononitrate, Linezolid may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, Linezolid may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[C04AA01, isoxsuprine, The risk or severity of hypertension can be increased when Linezolid is combined with Isoxsuprine.]
[B01AE06, bivalirudin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Bivalirudin.]
[L04AC07, tocilizumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Tocilizumab.]
[C02KD01, ketanserin, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Ketanserin.]
[B01AC22, prasugrel, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Prasugrel.]
[N05AH03, olanzapine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Olanzapine.]
[M02AA10, ketoprofen, The risk or severity of hypertension can be increased when Linezolid is combined with Ketoprofen.]
[L04AA24, abatacept, The risk or severity of adverse effects can be increased when Linezolid is combined with Abatacept.]
[C01CA22, arbutamine, The risk or severity of hypertension can be increased when Linezolid is combined with Arbutamine.]
[N04BC09, rotigotine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Rotigotine.]
[M01AE11, tiaprofenic acid, The risk or severity of hypertension can be increased when Linezolid is combined with Tiaprofenic acid.]
[C07AG01, labetalol, The risk or severity of hypertension can be increased when Linezolid is combined with Labetalol.]
[N04BB01, amantadine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Amantadine.]
[C02AA05, deserpidine, Linezolid may increase the hypotensive activities of Deserpidine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Linezolid.]
[N03AX18, lacosamide, The therapeutic efficacy of Lacosamide can be decreased when used in combination with Linezolid.]
[C03CC01, ethacrynic acid, Linezolid may increase the orthostatic hypotensive activities of Etacrynic acid.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Linezolid.]
[N04BA01, levodopa, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Lidocaine.]
[C03DB01, amiloride, Linezolid may increase the orthostatic hypotensive activities of Amiloride.]
[N02CA07, lisuride, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Lisuride.]
[N06AA07, lofepramine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Lofepramine.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Linezolid is combined with Lomustine.]
[N05BA06, lorazepam, The therapeutic efficacy of Lorazepam can be decreased when used in combination with Linezolid.]
[N05AH01, loxapine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Loxapine.]
[L01EG01, temsirolimus, The risk or severity of adverse effects can be increased when Linezolid is combined with Temsirolimus.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Linezolid.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Linezolid is combined with Pralatrexate.]
[L01EA03, nilotinib, The risk or severity of adverse effects can be increased when Linezolid is combined with Nilotinib.]
[V04CX04, mannitol, Linezolid may increase the orthostatic hypotensive activities of Mannitol.]
[N06AA21, maprotiline, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Maprotiline.]
[A08AA05, mazindol, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Mazindol.]
[C02BB01, mecamylamine, Linezolid may increase the hypotensive activities of Mecamylamine.]
[L01AA05, mechlorethamine, The risk or severity of adverse effects can be increased when Linezolid is combined with Mechlorethamine.]
[M02AA18, meclofenamic acid, The risk or severity of hypertension can be increased when Linezolid is combined with Meclofenamic acid.]
[N05BA03, medazepam, The therapeutic efficacy of Medazepam can be decreased when used in combination with Linezolid.]
[B01AB06, nadroparin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Nadroparin.]
[B01AB05, enoxaparin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Enoxaparin.]
[B01AB04, dalteparin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Dalteparin.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Linezolid is combined with Melphalan.]
[N02AB02, meperidine, The risk or severity of serotonin syndrome and opioid toxicity can be increased when Linezolid is combined with Meperidine.]
[C01CA11, mephentermine, The risk or severity of hypertension can be increased when Linezolid is combined with Mephentermine.]
[N03AB04, mephenytoin, The therapeutic efficacy of Mephenytoin can be decreased when used in combination with Linezolid.]
[N03AA01, mephobarbital, The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Linezolid.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Mepivacaine.]
[N02AX05, meptazinol, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Meptazinol.]
[N05AC03, mesoridazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Mesoridazine.]
[N05AX13, paliperidone, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Paliperidone.]
[C01CA09, metaraminol, The risk or severity of hypertension can be increased when Linezolid is combined with Metaraminol.]
[A10BA02, metformin, Linezolid may increase the hypoglycemic activities of Metformin.]
[A04AA04, dolasetron, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Dolasetron.]
[N07BC02, methadone, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Methadone.]
[N06BA03, methamphetamine, The risk or severity of hypertension can be increased when Linezolid is combined with Metamfetamine.]
[J05AF05, lamivudine, The excretion of Lamivudine can be decreased when combined with Linezolid.]
[N03AA30, metharbital, The therapeutic efficacy of Metharbital can be decreased when used in combination with Linezolid.]
[S01EC05, methazolamide, Linezolid may increase the orthostatic hypotensive activities of Methazolamide.]
[G02CB05, metergoline, The risk or severity of hypertension can be increased when Linezolid is combined with Metergoline.]
[H03BB02, methimazole, The risk or severity of adverse effects can be increased when Linezolid is combined with Methimazole.]
[L01BA04, pemetrexed, Linezolid may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[N05CA15, methohexital, The therapeutic efficacy of Methohexital can be decreased when used in combination with Linezolid.]
[L04AX03, methotrexate, The risk or severity of adverse effects can be increased when Methotrexate is combined with Linezolid.]
[N05AA02, methotrimeprazine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Methotrimeprazine.]
[C01CA10, methoxamine, The risk or severity of hypertension can be increased when Linezolid is combined with Methoxamine.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Linezolid.]
[C03AA08, methyclothiazide, Linezolid may increase the orthostatic hypotensive activities of Methyclothiazide.]
[C02AB01, methyldopa, Linezolid may decrease the hypotensive activities of Methyldopa.]
[V04CG05, methylene blue, Linezolid may increase the serotonergic activities of Methylene blue.]
[G02AB01, methylergonovine, The risk or severity of hypertension can be increased when Methylergometrine is combined with Linezolid.]
[N06BA04, methylphenidate, Linezolid may increase the hypertensive activities of Methylphenidate.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Linezolid is combined with Methylprednisolone.]
[N03AF03, rufinamide, The therapeutic efficacy of Rufinamide can be decreased when used in combination with Linezolid.]
[N02CA04, methysergide, The risk or severity of hypertension can be increased when Methysergide is combined with Linezolid.]
[A03FA01, metoclopramide, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Metoclopramide.]
[C03BA08, metolazone, Linezolid may increase the hypotensive activities of Metolazone.]
[C07AB02, metoprolol, Linezolid may increase the hypotensive activities of Metoprolol.]
[N06AX03, mianserin, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Mianserin.]
[N02BB03, aminopyrine, The risk or severity of hypertension can be increased when Linezolid is combined with Aminophenazone.]
[B01AB07, parnaparin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Parnaparin.]
[C01CA17, midodrine, The risk or severity of hypertension can be increased when Linezolid is combined with Midodrine.]
[G03XB01, mifepristone, Linezolid may increase the hypoglycemic activities of Mifepristone.]
[B01AB10, tinzaparin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Tinzaparin.]
[C09CA03, valsartan, Linezolid may increase the hypotensive activities of Valsartan.]
[D11AX01, minoxidil, Linezolid may increase the hypotensive activities of Minoxidil.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Linezolid is combined with Mitoxantrone.]
[N06BA12, lisdexamfetamine, The risk or severity of hypertension can be increased when Linezolid is combined with Lisdexamfetamine.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Linezolid is combined with Molindone.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Linezolid.]
[C01BD01, amiodarone, Linezolid may increase the orthostatic hypotensive activities of Amiodarone.]
[N06AA09, amitriptyline, Linezolid may increase the serotonergic activities of Amitriptyline.]
[N02AA01, morphine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Morphine.]
[A04AA05, palonosetron, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Palonosetron.]
[L04AB05, certolizumab pegol, The risk or severity of adverse effects can be increased when Linezolid is combined with Certolizumab pegol.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Ofatumumab.]
[L01EX03, pazopanib, The risk or severity of adverse effects can be increased when Linezolid is combined with Pazopanib.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Linezolid is combined with Mycophenolic acid.]
[N05CA02, amobarbital, The therapeutic efficacy of Amobarbital can be decreased when used in combination with Linezolid.]
[N06AA17, amoxapine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Amoxapine.]
[N03AB05, fosphenytoin, The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Linezolid.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Linezolid.]
[C07AA12, nadolol, Linezolid may increase the hypotensive activities of Nadolol.]
[N04BC04, ropinirole, Linezolid may increase the orthostatic hypotensive activities of Ropinirole.]
[N02AF02, nalbuphine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Nalbuphine.]
[N07BB04, naltrexone, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Naltrexone.]
[L04AC03, anakinra, The risk or severity of adverse effects can be increased when Anakinra is combined with Linezolid.]
[S01GA01, naphazoline, The risk or severity of hypertension can be increased when Linezolid is combined with Naphazoline.]
[N06BA01, amphetamine, The risk or severity of hypertension can be increased when Linezolid is combined with Amphetamine.]
[M02AA12, naproxen, The risk or severity of hypertension can be increased when Linezolid is combined with Naproxen.]
[A10BG01, troglitazone, Linezolid may increase the hypoglycemic activities of Troglitazone.]
[N06AX21, duloxetine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Duloxetine.]
[N04BX01, tolcapone, Linezolid may increase the orthostatic hypotensive activities of Tolcapone.]
[L01CD02, docetaxel, The risk or severity of adverse effects can be increased when Linezolid is combined with Docetaxel.]
[N01AH06, remifentanil, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Remifentanil.]
[A10BX02, repaglinide, Linezolid may increase the hypoglycemic activities of Repaglinide.]
[C01CX08, levosimendan, Linezolid may increase the orthostatic hypotensive activities of Levosimendan.]
[B01AC17, tirofiban, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Tirofiban.]
[N05AX14, iloperidone, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Iloperidone.]
[J02AA01, amphotericin B, Linezolid may increase the orthostatic hypotensive activities of Amphotericin B.]
[N06AX23, desvenlafaxine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Desvenlafaxine.]
[C09CA07, telmisartan, Linezolid may increase the hypotensive activities of Telmisartan.]
[J05AB11, valacyclovir, The excretion of Valaciclovir can be decreased when combined with Linezolid.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Linezolid.]
[N06AF02, nialamide, The risk or severity of serotonin syndrome can be increased when Nialamide is combined with Linezolid.]
[C08CA04, nicardipine, Linezolid may increase the hypotensive activities of Nicardipine.]
[C04AE02, nicergoline, The risk or severity of hypertension can be increased when Linezolid is combined with Nicergoline.]
[C08CA05, nifedipine, Linezolid may increase the orthostatic hypotensive activities of Nifedipine.]
[M02AA17, niflumic acid, The risk or severity of hypertension can be increased when Linezolid is combined with Niflumic acid.]
[V03AB22, amyl nitrite, Linezolid may increase the orthostatic hypotensive activities of Amyl Nitrite.]
[C08CA06, nimodipine, Linezolid may increase the hypotensive activities of Nimodipine.]
[C08CA07, nisoldipine, Linezolid may increase the hypotensive activities of Nisoldipine.]
[N05CD02, nitrazepam, The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Linezolid.]
[C08CA08, nitrendipine, Linezolid may increase the hypotensive activities of Nitrendipine.]
[R07AX01, nitric oxide, Linezolid may increase the orthostatic hypotensive activities of Nitric Oxide.]
[N05CF03, zaleplon, The therapeutic efficacy of Zaleplon can be decreased when used in combination with Linezolid.]
[N04BC05, pramipexole, Linezolid may increase the orthostatic hypotensive activities of Pramipexole.]
[C02DD01, nitroprusside, Linezolid may increase the hypotensive activities of Nitroprusside.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Linezolid.]
[C01CA03, norepinephrine, The risk or severity of hypertension can be increased when Linezolid is combined with Norepinephrine.]
[C02KX01, bosentan, Linezolid may increase the hypotensive activities of Bosentan.]
[N06AA10, nortriptyline, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Nortriptyline.]
[B01AC16, eptifibatide, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Eptifibatide.]
[G02CA02, nylidrin, The risk or severity of hypertension can be increased when Linezolid is combined with Nylidrin.]
[B01AB08, reviparin, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Reviparin.]
[L04AC04, rilonacept, The risk or severity of adverse effects can be increased when Linezolid is combined with Rilonacept.]
[N06AA05, opipramol, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Opipramol.]
[N02AA02, opium, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Opium.]
[R03CB03, metaproterenol, The risk or severity of hypertension can be increased when Linezolid is combined with Orciprenaline.]
[B01AD07, reteplase, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Reteplase.]
[B01AD09, ancrod, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Ancrod.]
[G04CA02, tamsulosin, Linezolid may increase the orthostatic hypotensive activities of Tamsulosin.]
[C07AA02, oxprenolol, Linezolid may increase the hypotensive activities of Oxprenolol.]
[N02AA05, oxycodone, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Oxycodone.]
[C01DX03, oxyfedrine, The risk or severity of hypertension can be increased when Linezolid is combined with Oxyfedrine.]
[S01GA04, oxymetazoline, The risk or severity of hypertension can be increased when Linezolid is combined with Oxymetazoline.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Oxymorphone is combined with Linezolid.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Linezolid is combined with Oxypertine.]
[S01BC02, oxyphenbutazone, The risk or severity of hypertension can be increased when Linezolid is combined with Oxyphenbutazone.]
[S01AA04, oxytetracycline, The excretion of Oxytetracycline can be decreased when combined with Linezolid.]
[V04CH30, 4-aminohippuric acid, The excretion of Aminohippuric acid can be decreased when combined with Linezolid.]
[N05AH05, asenapine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Asenapine.]
[B01AB09, danaparoid, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Danaparoid.]
[N02AX06, tapentadol, The risk or severity of adverse effects can be increased when Tapentadol is combined with Linezolid.]
[G04BE02, papaverine, Linezolid may increase the orthostatic hypotensive activities of Papaverine.]
[N05CC05, paraldehyde, The therapeutic efficacy of Paraldehyde can be decreased when used in combination with Linezolid.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Linezolid is combined with Paramethasone.]
[C02KC01, pargyline, The risk or severity of serotonin syndrome can be increased when Pargyline is combined with Linezolid.]
[C07AA23, penbutolol, Linezolid may increase the hypotensive activities of Penbutolol.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Linezolid is combined with Penfluridol.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Linezolid is combined with Penicillamine.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Linezolid.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Linezolid.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Linezolid.]
[N02AD01, pentazocine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Pentazocine.]
[N05CA01, pentobarbital, The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Linezolid.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Pentostatin is combined with Linezolid.]
[C04AD03, pentoxifylline, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Pentoxifylline.]
[N05AB10, perazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Perazine.]
[N04BC02, pergolide, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Pergolide.]
[N05AB03, perphenazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Perphenazine.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Linezolid.]
[N02AD02, phenazocine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Phenazocine.]
[N06AF03, phenelzine, The risk or severity of serotonin syndrome can be increased when Phenelzine is combined with Linezolid.]
[A10BA01, phenformin, Linezolid may increase the hypoglycemic activities of Phenformin.]
[B01AA02, phenindione, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Phenindione.]
[N03AA02, phenobarbital, The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Linezolid.]
[N01AH04, phenoperidine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Phenoperidine.]
[C04AX02, phenoxybenzamine, Linezolid may increase the hypotensive activities of Phenoxybenzamine.]
[B01AA04, phenprocoumon, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Phenprocoumon.]
[A08AA01, phentermine, The risk or severity of hypertension can be increased when Linezolid is combined with Phentermine.]
[V03AB36, phentolamine, Linezolid may increase the hypotensive activities of Phentolamine.]
[M02AA01, phenylbutazone, The risk or severity of hypertension can be increased when Linezolid is combined with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be increased when Linezolid is combined with Phenylephrine.]
[R01BA01, phenylpropanolamine, The risk or severity of hypertension can be increased when Linezolid is combined with Phenylpropanolamine.]
[N03AB02, phenytoin, The therapeutic efficacy of Phenytoin can be decreased when used in combination with Linezolid.]
[L04AB06, golimumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Golimumab.]
[S01AE05, levofloxacin, The excretion of Levofloxacin can be decreased when combined with Linezolid.]
[N07BB03, acamprosate, The excretion of Acamprosate can be decreased when combined with Linezolid.]
[J05AB12, cidofovir, The excretion of Cidofovir can be decreased when combined with Linezolid.]
[C08CX01, mibefradil, Linezolid may increase the hypotensive activities of Mibefradil.]
[N05AG02, pimozide, The risk or severity of adverse effects can be increased when Linezolid is combined with Pimozide.]
[C07AA03, pindolol, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Pindolol.]
[J01CA12, piperacillin, The excretion of Piperacillin can be decreased when combined with Linezolid.]
[N05AC04, pipothiazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Pipotiazine.]
[C09CA02, eprosartan, Linezolid may increase the hypotensive activities of Eprosartan.]
[N02AC03, pirinitramide, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Piritramide.]
[S01BC06, piroxicam, The risk or severity of hypertension can be increased when Piroxicam is combined with Linezolid.]
[J01MA11, grepafloxacin, The excretion of Grepafloxacin can be decreased when combined with Linezolid.]
[N02CX01, pizotyline, Linezolid may increase the anticholinergic activities of Pizotifen.]
[C09CA04, irbesartan, Linezolid may increase the hypotensive activities of Irbesartan.]
[B01AC13, abciximab, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Abciximab.]
[S01XA13, alteplase, The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Alteplase.]
[A10BG02, rosiglitazone, Linezolid may increase the hypoglycemic activities of Rosiglitazone.]
[L04AC08, canakinumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Canakinumab.]
[C03AA05, polythiazide, The excretion of Polythiazide can be decreased when combined with Linezolid.]
[A10BH03, saxagliptin, The excretion of Saxagliptin can be decreased when combined with Linezolid.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Linezolid is combined with Insulin lispro.]
[C07AB01, practolol, Linezolid may increase the hypotensive activities of Practolol.]
[C02CA01, prazosin, Linezolid may increase the hypotensive activities of Prazosin.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Linezolid is combined with Prednisolone.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Linezolid is combined with Prednisone.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Linezolid is combined with Prilocaine.]
[N03AA03, primidone, The therapeutic efficacy of Primidone can be decreased when used in combination with Linezolid.]
[S01HA05, procaine, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Linezolid.]
[L01XB01, procarbazine, The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Linezolid.]
[N05AB04, prochlorperazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Prochlorperazine.]
[N05AA03, promazine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Promazine.]
[R06AD02, promethazine, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Promethazine.]
[C01BC03, propafenone, The risk or severity of hypertension can be increased when Linezolid is combined with Propafenone.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Linezolid.]
[N05AC01, periciazine, The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Periciazine.]
[N05CM06, propiomazine, The risk or severity of hypertension can be increased when Linezolid is combined with Propiomazine.]
[N01AX10, propofol, Linezolid may increase the orthostatic hypotensive activities of Propofol.]
[N02AC04, propoxyphene, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Dextropropoxyphene.]
[C07AA05, propranolol, Linezolid may increase the hypotensive activities of Propranolol.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Linezolid.]
[N02CC04, rizatriptan, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Rizatriptan.]
[B01AC09, epoprostenol, Linezolid may increase the hypotensive activities of Epoprostenol.]
[N06AA11, protriptyline, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Protriptyline.]
[R01BA02, pseudoephedrine, The risk or severity of hypertension can be increased when Linezolid is combined with Pseudoephedrine.]
[N05AX12, aripiprazole, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Aripiprazole.]
[N07XX07, dalfampridine, The risk or severity of seizure can be increased when Linezolid is combined with Dalfampridine.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Linezolid.]
[C01BA01, quinidine, The risk or severity of hypertension can be increased when Linezolid is combined with Quinidine.]
[P01BC01, quinine, Linezolid may increase the hypoglycemic activities of Quinine.]
[A02BA02, ranitidine, The excretion of Ranitidine can be decreased when combined with Linezolid.]
[C02AA01, rescinnamine, Linezolid may increase the hypotensive activities of Rescinnamine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Linezolid is combined with Reserpine.]
[J04AB02, rifampin, The therapeutic efficacy of Linezolid can be decreased when used in combination with Rifampicin.]
[R03AC05, rimiterol, The risk or severity of hypertension can be increased when Linezolid is combined with Rimiterol.]
[G02CA01, ritodrine, The risk or severity of hypertension can be increased when Linezolid is combined with Ritodrine.]
[N02BA05, salicylamide, The risk or severity of hypertension can be increased when Linezolid is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of adverse effects can be increased when Linezolid is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of hypertension can be increased when Linezolid is combined with Salicylic acid.]
[N05CA06, secobarbital, The therapeutic efficacy of Secobarbital can be decreased when used in combination with Linezolid.]
[N04BD01, selegiline, The risk or severity of serotonin syndrome can be increased when Selegiline is combined with Linezolid.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Linezolid is combined with Obinutuzumab.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Linezolid.]
[C07AA07, sotalol, Linezolid may increase the orthostatic hypotensive activities of Sotalol.]
[L01CD04, cabazitaxel, The risk or severity of adverse effects can be increased when Linezolid is combined with Cabazitaxel.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Linezolid.]
[C03DA01, spironolactone, Linezolid may increase the orthostatic hypotensive activities of Spironolactone.]
[L01FD03, ado-trastuzumab emtansine, The risk or severity of adverse effects can be increased when Linezolid is combined with Trastuzumab emtansine.]
[N03AG01, valproic acid, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Linezolid is combined with Hydrocortisone butyrate.]
